Sacituzumab a 'Step Forward' in Breast Cancer Unmet Need

Sacituzumab govitecan (Trodelvy) beat chemotherapy in patients with heavily pretreated endocrine resistant HR+/HER2- advanced breast cancer, who represent a 'great clinical unmet need,' says expert.
Medscape Medical News

source https://www.medscape.com/viewarticle/975069?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost